Chlorogenic acid modifies plasma and liver concentrations of: Cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats

Journal of Nutritional Biochemistry

Volumn 13, Issue 12, 2002, Pages 717-726

  Rodriguez de Sotillo, Delcy V ^a   Hadley, M ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Chlorogenic acid; Glucose tolerance; Hypolipidemic effect; Improved magnesium concentrations; Triacylglycerols; Zucker (fa fa) rats

Indexed keywords

CHLOROGENIC ACID; CHOLESTEROL; MINERAL; TRIACYLGLYCEROL;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; IN VIVO STUDY; LIPID LIVER LEVEL; MINERAL BLOOD LEVEL; NONHUMAN; OBESITY; RAT STRAIN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036903553     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00231-0     Document Type: Article

References (48)

1. Kao W., Folsom A., Nieto F., Mo J., Watson R., Brancati F. Serum and dietary magnesium and the risk for type 2 diabetes mellitus, the atherosclerosis risk in communities study. Arch. Intern. Med. 159:1999;2151-2159.
2. Paolisso G., Ravussin E. Intracellular magnesium and insulin resistance results in Pima Indians and Caucasians . J. Clin. Endocrinol. Metab. 80:1995;1382-1385.
3. Howard B.V. Kritchevsky, Phytochemicals and cardiovascular disease, a statement for healthcare professionals from the American Heart Association. Circulation. 95:1997;2591-2593.
4. Hemmerle H., Burger H.J., Below P., Schubert G., Rippel R., Schindler P.W., Paulus E., Herling A.W. Chlorogenic acid and synthetic chlorogenic acid derivatives novel inhibitors of hepatic glucose-6-translocase . J. Med. Chem. 40:1997;137-145.
5. Nardini M., D'Aquino M., Tomassi G., Gentili V., Di-Felice M., Scaccini C. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic. Biol. Med. 19:1995;541-552.
6. Nardini M., Natella F., Gentili V., Di-Felice M., Scaccini C. Effect of caffeic acid dietary supplementation on the antioxidant defense system in rat an in vivo study . Arch. Biochem. Biophys. 342:1997;157-160.
7. Choudhury R., Srai S.K., Debnam E., Rice-Evans C.A. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic. Biol. Med. 27:1999;278-286.
8. Azuma K., Ippoushi K., Nakayama M., Ito H., Higashio H., Terao J. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J. Agric. Food Chem. 48:2000;5496-5500.
9. Plumb G., Garcia-Conesa M., Kroon P., Rhodes M., Ridley S., Williamson G. Metabolism of chlorogenic acid by human plasma liver intestine and gut microflora. J. Sci. Food Agric. 79:1999;390-392.
10. Mazur A., Gueux E., Remesy C., Demigne C., Rayssiguier Y. Plasma and red blood cell magnesium concentrations in Zucker rats influence of a high fibre diet . Magnes. Res. 2:1989;189-192.
11. Ewis S., Abdel-Rahman M. Effects of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats. J. Appl. Toxicol. 15:1995;387-390.
12. Walser M. Magnesium metabolism. Ergeb Physiol. 59:1967;185-296.
13. Kono Y., Kashine S., Yoneyama T., Sakamoto Y. Iron chelation by chlorogenic acid as a natural antioxidant. Biosci. Biotech. Biochem. 62:1998;22-27.
14. Ewis S., Abdel-Rahman M. Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats. J. Appl. Toxicol. 17:1997;409-413.
15. Gosnell B.A., Lane K.E., Bell S.M., Krahn D.D. Intravenous morphine self- administration by rats with low versus high saccharin preferences. Psychopharmacology. 117:1995;248-252.
16. Iritani N., Sugimoto T., Fukuda H., Komiya M., Ikeda H. Dietary soybean protein increases receptor gene expression in Wistar rats when dietary polyunsaturated fatty acid level is low. J. Nutr. 127:1997;1077-1083.
17. Lazarov K., Werman M. Hypocholesterolaemic effect of potato peels as a dietary fibre source. Med. Sci. Res. 9:1996;581-584.
18. Bok S.H., Lee S.H., Park Y.B., Bae K.H., Son K.H., Jeong T.S., Choi M.S. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl CoA- reductase and acyl CoA cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids . J. Nutr. 129:1999;1182-1185.
19. SAS® User's Guide, Basic Statistics. 5th ed. 1985;SAS Institute Inc. Cary, NC Inc.
20. Gueux E., Rayssiguier Y. The effect of magnesium deficiency on glucose stimulated insulin secretion in rats. Horm. Metab. Res. 15:1983;594-597.
21. Schirardin H., Bach A., Schaeffer A., Bauer M., Weryha A. Biological parameters of the blood in the genetically obese Zucker rat. Arch. Int. Physiol. Biochim. 87:1979;275-289.
22. Levin N.W., Hoenich N.A. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr. Opin. Nephrol. Hypertens. 10:2001;563-568.
23. Balon T.W., Gu J.L., Tokuyama Y., Jasman A.P., Nadler J. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol. 269:1995;745-752.
24. Saladino C., Schneider M., Jonas E., Grimes G. Parenteral lipid emulsion-induced atherosclerosis in the obese Zucker rat and its lean littermate. Artery. 19:1992;297-306.
25. Gavrilescu S., Luca C., Fiat F. Effect of potassium and magnesium aspartate on the serum free-fatty-acids levels in patients with acute myocardial infarction. Agressologie. 15:1974;87-91.
26. Johnson P., Stern J., Horwitz B., Harris R., Greene S. Longevity in obese and lean male and female rats of the Zucker strain prevention of hyperphagia . Am. J. Clin. Nutr. 66:1997;890-903.
27. Zabetakis P., Nissenson A. Complications of chronic renal insufficiency beyond cardiovascular disease . Am. J. Kidney Dis. 36:2000;31-38.
28. Van-den-Berg G., Yu S., Lemmens A., Beynen A. Ascorbic acid feeding of rats reduces copper absorption causing impaired copper status and depressed biliary copper excretion. Biol. Trace Elem. Res. 41:1994;47-58.
29. Harris E., Percival S. A role for ascorbic acid in copper transport. Am. J. Clin. Nutr. 54:1991;1193-1197.
30. Hamdaoui M., Hedhili A., Doghri T., Tritar B. Effect of tea decoction given to rats ad libitum for a relatively long time on body weight gains and iron copper, zinc, magnesium concentrations in blood, liver, duodenum and spleen. Ann. Nutr. Metab. 41:1997;196-202.
31. H.N, Graham Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 21:1992;334-350.
32. Bus J.S., Popp J.A. Perspectives on the mechanism of action of the spleenic toxicity of aniline structurally-related compounds. Food Chem. Toxic. 25:1987;619-626.
33. Coudray C., Bousset C., Tressol J.C., Pepin D., Rayssiguier Y. Short-term ingestion of chlorogenic or caffeic acids decreases zinc but not copper absorption in rats, utilization of stable isotopes inductively-coupled plasma mass spectrometry technique. Brit. J. Nutr. 80:1998;575-584.
34. Car N., Car A., Granic M., Skrabalo Z., Momcilovic B. Zinc and copper in the serum of diabetic patients. Biol. Trace Elem. Res. 32:1992;325-329.
35. Tobia M., Zdanowicz M., Wingertzahn M., McHeffey-Atkinson B., Slonim A., Wapnir R. The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat. Mol. Genet. Metab. 63:1998;205-213.
36. Failla M., Gardell C. Influence of spontaneous diabetes on tissue status of zinc, copper, and manganese in the BB Wistar rat. Proc. Soc. Exp. Biol. Med. 180:1985;317-322.
37. Ganda O. Secondary forms of diabetes. Kahn A.R., Weir G.C. Joslin's Diabetes Mellitus. 1994;300-316 Lea & Febiger Publishers, Malvern, PA.
38. Nakane S., Shirabe S., Suenaga A., Yoshimura T., Nakamura T., Rinsho-Shinkeigaku T. A case of hereditary ceruloplasmin deficiency with hemosiderosis. Rinsho Shinkeigaku. 39:1999;347-351.
39. Tokuyama Y., Sturis J., DePaoli A.M., Takeda J., Stoffel M., Tang J., Sun X., Polonsky K.S., Bell G.I. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes. 44:1995;1447-1457.
40. Yakubu-Madus F., Stephens T., Johnson W. Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione 5-(4-2-phenyl-4-oxazoly ethoxy benzyl)-2 4 thiazolidinedione. Diabetes Obesity Metabolism. 2:2000;155-163.
41. Russell J.C., Shillabeer G., Bar Tana J., Lau D., Richardson M., Wenzel L., Graham S., Dolphin P. Development of insulin resistance in the JCR LA-cp rat role of triacylglycerols and effects of medica 16 . Diabetes. 47:1998;770-778.
42. Aiston S., Peak M., Agius L. Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats the role of increased phosphorylase activity . Diabetologia. 43:2000;589-597.
43. Bach A., Schirardin H., Bauer M., Schaeffer A., Weryha A. Age-related changes in biological parameters in Zucker rats. Lipids. 16:1981;841-848.
44. Lebovitz H.E. Oral antidiabetic agents. Kahn A.R., Weir G.C. Joslin's Diabetes Mellitus. 1994;508-530 Lea & Febiger Publishers, Malvern, PA.
45. Daubioul C., Taper H., De-Wispelaere L., Delzenne N. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J. Nutr. 130:2000;1314-1319.
46. Rohner-Jeanrenaud F., Proietto E., Ionescu E., Jeanrenaud B. Mechanism of abnormal glucose tolerance of genetically obese fa/fa rats. Diabetes. 35:1986;1350-1355.
47. Engelgau M., Thompson T., Herman W., Boyle J., Aubert R., Kenny S., Badran A., Sous E., Ali M. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes diagnostic criteria and performance revised . Diabetes Care. 20:1997;785-791.
48. Bailey C.J., Flatt P., Ewan C. Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice. Arch. Int. Pharmacodyn. Ther. 282:1986;233-239.